CytoMed Therapeutics Statistics
NASDAQ: GDTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.9449-0.0349 (-3.56%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
CytoMed Therapeutics by the numbers
CytoMed Therapeutics has a market capitalization of $11.3 million based on 11.93M shares outstanding. With trailing EPS of $-0.23, CytoMed Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.1% above its 50-day average and 7.3% below its 200-day average.
Average daily trading volume is 78.41K shares, or about $74,090 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GDTC valuation vs. peer median
| Metric | GDTC | Peer median | Difference |
|---|---|---|---|
| Market cap | $11.28M | $11.15M | +1% |
| Avg. volume | 78.41K | 118.69K | -34% |
Peer median across 8 companies: ASBP, PHIO, KPRX, BIVI, BLRX, LTRN, VTGN, GTBP.
Valuation
- Market cap
- $11.28M
- EPS (TTM)
- $-0.23
- Shares outstanding
- 11.93M
Price and trading
- Previous close
- 0.9798
- Open
- 0.90
- Day range
- 0.90 – 0.9449
- 52-week range
- 0.68 – 3.68
- 52-week change
- -54.63%
- 50-day moving average
- 0.8989
- Beta
- —
- Volume
- 23.22K
- Average volume
- 78.41K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Apr 28, 2025
Additional statistics
- Market Cap
- 11.28M
- Forward Pe
- -6.30
- Eps
- -0.23
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.68
- Week52 Low
- 0.68
- Avg Volume
- 78,410.00
- Shares Outstanding
- 11.93M
- Ma50
- 0.90
- Ma200
- 1.02
- Earnings Date
- Apr 28, 2025
- Pct From52w High
- -74.32%
- Pct From52w Low
- 38.96%